The NanoBioFaces research group presented the European project “Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products – PHOENIX” at the 10th Symposium of Pharmacy and Medical Biochemistry Students (FARMEBS 2022) on Saturday, October 22, 2022 at the Faculty of Pharmacy and Biochemistry.

NanoBioFaces group from the Institute for Medical Research and Occupational Health, headed by Dr. sc. Ivana Vinković Vrček, leads the “Regulatory Support” Work Package in the Phoenix project, and participates in the development and application of in vivo and in vitro methods for assessing the safety and effectiveness of nanomedicines. During the workshop, Dr. sc. Ivana Vinković Vrček and her colleagues presented the project itself in more detail, as well as the activities and methods that are developed and used as part of the research work of the group.

Where it was presented that PHOENIX, a project financed from the Horizon 2020 program, has as its ultimate goal to offer the market a united network of companies and laboratories that, with their expertise in research, development, production and regulatory activities in the field of nanomedicine, will facilitate the development of nanomedicine formulations from laboratory to preclinical and production processes. During the 4 years of the project, 12 partner institutions from 6 European countries will upgrade their existing laboratories and production facilities, build new ones, and provide services through the so-called “single-entry point” approach. The services will cover design, development, preclinical testing, scale-up development, GMP production and regulatory support for all phases of nanomedicine development.

Leave a Reply

Your email address will not be published. Required fields are marked *